Quince Therapeutics, Inc. (QNCX)
1.30
+0.08
(+6.56%)
USD |
NASDAQ |
May 07, 14:30
Quince Therapeutics SG&A Expense (TTM) : 15.05M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Recursion Pharmaceuticals, Inc. | 121.94M |
| Ocular Therapeutix, Inc. | 87.80M |
| Gossamer Bio, Inc. | 37.63M |
| Ernexa Therapeutics, Inc. | 5.162M |
| Acurx Pharmaceuticals, Inc. | 6.230M |